Aiforia
What They Do[edit]
AI-powered pathology platform for analyzing tissue samples. Received European approval for AI-assisted breast cancer diagnosis. Used in hospital laboratories across Europe.
Funding[edit]
Valuation: ~€100M+ (Nasdaq-listed) Multiple rounds. Publicly listed on Nasdaq Helsinki.
Revenue[edit]
Source: allabolag.se / company reports